Early symptomatic Alzheimer’s disease (eAD) research hub

First-in-human study of RO7812653

This study is testing a new medicine, RO7812653, for early Alzheimer's disease. We want to see if it's safe, how it works in the body, and if it could help. Some people will get the medicine, others a dummy treatment (placebo), given by injection into the lower back.